March 26, 2025 - 07:58

Grounded in data, research by an Associate Professor at MIT Sloan School of Management, Christopher Palmer, provides valuable insights into personal money management. His work delves into the broader economic scenarios that lead individuals to experience financial strain, offering a comprehensive view of how external factors influence personal finance decisions.
Palmer's research focuses particularly on consumer behavior related to credit usage. He examines how various economic conditions can affect individuals' perceptions and management of their finances. By analyzing patterns in credit behavior, he highlights the challenges many face when navigating financial pressures, especially in times of economic uncertainty.
This research not only emphasizes the importance of understanding personal credit but also encourages consumers to approach their financial decisions with a more informed perspective. As economic conditions fluctuate, insights from this study can help individuals better manage their financial health and make more strategic choices regarding credit and spending.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...